GLP-1 without insurance: what it actually costs

If you have no coverage, the honest headline is that 2026 was a better year for you than any before it. The approved products got much cheaper for cash buyers, and the gap that made compounded the only realistic option narrowed a long way.

Start with the federal cash price

The federal government launched TrumpRx.gov on 6 February 2026, a direct to patient purchasing website created after most favoured nation pricing agreements with several manufacturers.

What it is and is not. It is not a pharmacy and it does not prescribe. You need a prescription you already hold. The site provides a coupon you print or keep on your phone, and you buy at a participating pharmacy.

Prices published by the White House at launch:

Around 40 branded medicines were covered at launch across several categories. Controlled substances and drugs under certain federal safety programmes are excluded, which does not affect GLP-1s.

For most uninsured people wanting an FDA approved product, this is the route to check first.

You still need a prescription

That is the part people trip over. A cash price does not remove the requirement for a clinician to prescribe, which means either an in-person visit or a telehealth consultation.

That consultation has its own cost, and if it comes through a subscription service you should establish what that fee is, whether it recurs, and how you cancel, before you enter a card.

What compounded costs, and what you give up

Compounded semaglutide and tirzepatide still generally carry the lowest sticker price. What you give up in exchange:

• It is not an FDA approved product and is not reviewed for safety, effectiveness or quality before sale.
• The only comparison study available found compounded semaglutide slightly behind the approved version on average weight loss, and meaningfully behind at the higher thresholds.
• The legal basis narrowed in 2025 when the FDA determined the shortages were resolved.

A year ago, choosing compounded meant paying a few hundred dollars instead of over a thousand. Now it often means paying somewhat less than $199 to $350. That is a different trade off, and worth recalculating.

What the grey market costs, and why the price is the smallest part

Below compounded sits product sold without a prescription, often labelled for research use and frequently carrying wording to the effect of not for human consumption.

Researchers have bought and tested these. A 2024 study in JAMA Network Open assessed semaglutide bought online without a prescription and found safety and quality problems. A 2024 study in the Journal of Medical Internet Research surveyed sellers, bought product and found problems across the market. A 2025 paper described an international supply chain running largely outside any regulatory system.

The FDA has separately warned about fraudulent product with false label information, counterfeits that may contain the wrong ingredient or none, and salt forms it considers different active ingredients from those in approved drugs.

We are not going to lecture anyone priced out of the system. We will say that the money saved is small against what is being given up, and that the federal cash route did not exist when most people made this choice.

Reduce the cost honestly

Check whether you are eligible for coverage you do not think you have. Medicaid eligibility varies by state and changes. Marketplace plans have annual open enrollment, and for 2027 coverage on the federal platform that runs 1 November to 15 December 2026. If you are 65 or older or otherwise Medicare eligible, the Medicare GLP-1 Bridge is fifty dollars a month.

Ask about the specific product. Prices differ between products and between the diabetes and weight management brands of the same molecule.

Compare total annual cost at your target dose, not the introductory month.

Check the cancellation terms before paying. Federal enforcement in this category has focused heavily on subscription billing.

What it is worth knowing before you commit

These are not short courses. A meta-analysis of 11 studies covering 12,539 people found that after stopping a high dose GLP-1, 50 to 65 percent of the weight lost came back within twelve months, most of it in the first three to six.

So the question is not what you can afford this month. It is what you can afford to keep doing.

What to ask

• What is the TrumpRx price for the exact product I want?
• What will the consultation cost, and is it recurring?
• Am I actually ineligible for Medicaid, a marketplace plan, or Medicare?
• What is my total cost at target dose for a full year?
• How do I cancel?

Sources

• The White House, Fact Sheet on the launch of TrumpRx.gov, 6 February 2026
• Executive Order, Delivering Most-Favored-Nation Prescription Drug Pricing, 12 May 2025
• Centers for Medicare and Medicaid Services, Medicare GLP-1 Bridge
• Centers for Medicare and Medicaid Services, key dates for the Health Insurance Marketplace
• FDA, "FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss"
• Safety and Risk Assessment of No-Prescription Online Semaglutide Purchases. JAMA Network Open, 2024. doi:10.1001/jamanetworkopen.2024.28280
• Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription. Journal of Medical Internet Research, 2024. doi:10.2196/65440
• Talay L, Vickers M. Retrospective comparison of compounded and FDA approved semaglutide in a digital weight loss service, 2024
• Weight regain after discontinuation of high dose GLP-1 receptor agonists, meta-analysis of 11 studies, 2026

How we verify: see /how-we-verify.

Keep reading

All four routes compared side by side, at /guides/how-to-pay-for-glp1.

How to get a GLP-1 covered by insurance, at /guides/get-glp1-covered-by-insurance.